Seoul, South Korea

Dong Hyuk Nam

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Dong Hyuk Nam in Pharmaceutical Chemistry

Introduction

Dong Hyuk Nam is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for drug preparation. His innovative approach has led to advancements in the synthesis of important medications.

Latest Patents

Dong Hyuk Nam holds a patent for a novel method for the preparation of atorvastatin and the intermediates used therein. This invention relates to a safe and efficient method for producing atorvastatin, a crucial medication for lowering cholesterol levels. The patent highlights a unique intermediate that facilitates the large-scale production of atorvastatin, ensuring both safety and efficacy in its preparation.

Career Highlights

Dong Hyuk Nam is associated with Chong Kun Dang Pharmaceutical Corporation, a leading pharmaceutical company in South Korea. His work at the company has been instrumental in advancing pharmaceutical research and development. With a focus on innovative drug preparation methods, he has contributed to the company's reputation for excellence in the industry.

Collaborations

Dong Hyuk Nam has collaborated with notable colleagues, including Soon Kil Ahn and Hong-Woo Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.

Conclusion

Dong Hyuk Nam's contributions to pharmaceutical chemistry, particularly through his patent for atorvastatin preparation, underscore his role as a key innovator in the field. His work continues to impact the pharmaceutical industry positively, paving the way for safer and more effective medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…